health pharma news today obesity drugs glp-1 A new oral option is now part of medicine. FDA approved Foundayo (orforglipron), a once-daily oral GLP-1 receptor agonist, for adults with obesity or overweight with at least one weight-related GLP-1 Medications for Weight Loss:

This observation hints at the plausible role of the C201-G202 dipeptide as a glutathione mimic, i.e

29,30 Physiology of GGT Origin and Formation of GGT The enzyme gamma-glutamyl transferase (GGT) is a protein that binds substrates through active sites.31

beta-Caryophyllene suppresses ferroptosis induced by cerebral ischemia reperfusion via activation of the NRF2/HO-1 signaling pathway in MCAO/R rats

Among 69,221 propensity-matched patients with IBD, those who had received a GLP-1 RA had a 5-year colorectal cancer incidence of 0.2% compared with 0.42% in non-GLP-1 RA users (OR, 0.49), corresponding to a 51% reduction in odds of developing colorectal cancer